Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted

December 2010

Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted.

Its use has also been restricted in the U.S. and suspended in Europe...due to the possible increased risk of cardiovascular events.

The new restrictions apply to both current and new patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Neurology & Pain new formulations of controlled-release oxycodone...Targin in Canada and OxyContin "OP" in the U.S.
Diabetes Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted
Diabetes More diabetes patients will use insulin pumps
Cardiology whether hypertension should be treated more aggressively in black patients than in other races
Gastroenterology LESS use of triple therapy to eradicate H. pylori
Chronic Pain Cymbalta (duloxetine) will be used more for chronic musculoskeletal pain in the lower back or due to osteoarthritis
Renal & Urology what to use for UTI pain now that phenazopyridine (Phenazo, Pyridium) is off the market
Women's Health whether postmenopausal estrogen plus progestin therapy increases breast cancer risk
Epilepsy new epilepsy drug called Vimpat (lacosamide)
Psychiatry Meds cause about 10% of cases of Parkinson-like motor symptoms
Vaccines changes in the recommendations for varicella, rotavirus, and pneumococcal vaccines for children
Counseling improving patient communication